PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma
PSMD11 and PSMD14 are highly expressed in pancreatic ductal adenocarcinoma tissues and are correlated with the degree of malignancy of pancreatic ductal adenocarcinoma; thus, PSMD11 and PSMD14 can be used as potential prognostic biomarkers and therapeutic targets for PDAC patients.
Authors
- Dahuan Li
- Fangfei Liu (ORCID: https://orcid.org/0000-0003-1779-8541)
- Xing Zhao (ORCID: https://orcid.org/0000-0002-1439-6275)
- Qianming Bai (ORCID: https://orcid.org/0000-0003-0657-9845)
- Hao Wang (ORCID: https://orcid.org/0000-0001-7661-3688)
- Chi Zhang (ORCID: https://orcid.org/0000-0002-4826-7877)
- Yubo Liu (ORCID: https://orcid.org/0000-0002-1413-0987)
- Weifeng Liu (ORCID: https://orcid.org/0000-0001-8462-8820)
- Jing Yang (ORCID: https://orcid.org/0009-0003-2199-8623)
- Hua Fan (ORCID: https://orcid.org/0000-0002-7652-2820)
- Yanhui Yang (ORCID: https://orcid.org/0000-0003-3896-916X)
Institutions
- First Affiliated Hospital of Henan University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3389/fonc.2025.1555649
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04